The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC): Initial Pilot Feasibility Study to Assess Patient Awareness and Risk Mitigation
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- CARE-PC Web-Based Application Completion Rate
研究概览
简要总结
The overarching goal of this trial is to develop mechanisms to improve cardiovascular care among such prostate cancer patients receiving ADT by increasing patient awareness of individualized cardiovascular risk estimates and mitigation opportunities. Patients will be given access to a web-based quality improvement tool to educate patients of cardiovascular risks in prostate cancer and to inform them of their individualized, estimated cardiovascular risk and guideline-based risk mitigation recommendations.
The study will assess the feasibility of this web-based application as a cardiovascular education tool for patients with prostate cancer.
The study will also evaluate if completion of the web-based tool improves cardiovascular care access and risk mitigation for patients with prostate cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Men with prostate cancer > 18 years of age who are currently receiving or will be receiving treatment with ≥ 6 months of ADT
- •Patients must be able to read and understand English.
排除标准
- 未提供
研究组 & 干预措施
Men With Prostate Cancer Planned for Receiving ADT
Men with prostate cancer > 18 years of age who are currently receiving or will be receiving treatment with ≥ 6 months of systemic androgen deprivation therapy (ADT).
干预措施: CARE-PC Web-Based Application (Behavioral)
结局指标
主要结局
CARE-PC Web-Based Application Completion Rate
时间窗: 18 months
Completion rate measured as the proportion of participants successfully completing the web-based application out of the total number of subjects approached.
次要结局
- Percent accuracy of patient-derived CV- and prostate cancer-related data elements(18 months)
- Proportion of participants having changes in CV risk-reducing medications within 6 months of CARE-PC application participation.(18 months)
- Prevalence of CV risk factors/disease at the time of CARE-PC web-based application participation(18 months)
- Proportion of participants engaging in CV care within 6 months of CARE-PC web application participation(18 months)
- Patient acceptance and perception of the web-based application(18 months)
- Proportion of participants with current cardiologist involvement in CV care at the time of web-based application participation(18 months)
研究者
Vivek Narayan
Principal Investigator
Abramson Cancer Center at Penn Medicine